This suggests that Galunisertib may regulate the autophagy-lysosomal system through the TGF-β/TRAF6/Beclin1 signaling pathway, thereby reducing cell apoptosis and improving fibrosis in silicosis mice. Here, BECN1 is linked to silicosis.